Basket | Login


José Luis Molinuevo


The work and research activities of Dr José L. Molinuevo (MD, PhD), neurologist, are related to neurodegenerative diseases, mostly Alzheimer’s disease (AD) and related disorders. His MD career was performed at the University of Valencia, his neurology training at the Hospital Clinic de Barcelona, and his PhD, on Parkinson’s disease (PD) was completed at the University of Barcelona. Nowadays, he directs the Alzheimer’s disease and other cognitive disorders unit at the Hospital Clinic de Barcelona, which includes a genetic counselling program for monogenic dementias (PICOGEN). He is also the Scientific Director of the BarcelonaBeta Brain Research Centre of the Fundación Pasqual Maragall.

He is a researcher at the IDIBAPS, a member of the European Alzheimer Disease Consortium, of the dementia panel for the European Association of Neurology, of the Alzheimer Biomarker Standarization Initiative (ABSI), the Spanish coordinator of the BIOMARKAPD of the Joint Programming on Neurodegenerative Diseases, partner of several Innovative Medicine Initiative consortiums, such as EMIF AD, AETIONOMY, EPAD, and part of the International Working Group for developing new research criteria. He is principal investigator of multiple clinical trials and research studies on AD, and has presented data and worked as external consultant, advisor or member of trial executive committees and data monitoring boards for the following companies: Novartis, Pfizer, Eisai, Janssen-Cilag, Lundbeck, Roche, Bayer, Bristol-Myers Squibb, GE Health Care, Piramal, Merz, MSD, GlaxoSmithKline, Astra-Zeneca, Avid, Lilly, Boehringer-Ingelmein, Biokit, Roche-diagnostics, IBL, Fujireibio-Europe and Axovant.

He has published over 200 international scientific papers, several books and over 20 book chapters on neurodegenerative diseases. He was part of the board of directors of the Spanish Neurological Society from 2000-2002 and coordinated the dementia scientific group from 2006-2008. He was awarded with the ICGP international junior investigator award in 2003 and with the AD scientific prize of the Spanish Neurological Society in 2010.



Last Updated: Monday 29 February 2016